GNAS1 T393C polymorphism and disease progression in patients with malignant melanoma

GNAS1 T393C polymorphism and disease progression in patients with malignant melanoma

<p>Abstract</p> <p>Background</p> <p>Once metastasized, despite a variety of therapeutic options, the prognosis of patients with malignant melanoma (MM) is still poor. Therefore, the search for reliable markers to identify patients with high risk of disease progression...

Full description

Bibliographic Details
Main Authors: Frey UH, Fritz A, Rotterdam S, Schmid KW, Potthoff A, Altmeyer P, Siffert W, Brockmeyer NH
Format: Article
Language:English
Published: BMC 2010-10-01
Series:European Journal of Medical Research
Subjects:
polymorphism
G Protein
melanoma
pro gnostic factor
Online Access:http://www.eurjmedres.com/content/15/10/422

Internet

http://www.eurjmedres.com/content/15/10/422

Similar Items